Literature DB >> 9109889

Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity.

H Buschke1, M J Sliwinski, G Kuslansky, R B Lipton.   

Abstract

OBJECTIVE: To compare the Double Memory Test (DMT) with standard memory tests in the diagnosis of early dementia.
BACKGROUND: Diagnosis of dementia requires memory impairment, but few memory tests coordinate acquisition and retrieval to optimize encoding specificity for high sensitivity and specificity. The DMT was developed to improve early diagnosis.
DESIGN: We compared the discriminative validity of the DMT, Paired Associates (PA), and Logical Memory (LM) memory tests in a nested case-control study of 30 cases of early dementia and 90 controls matched for age, education, and sex.
METHODS: The DMT includes memory tests with (CCR) and without (ICR) encoding specificity. Both tests use category cues to elicit retrieval, but CCR optimizes encoding specificity because the same cues are used for acquisition and retrieval. ICR does not because category cues are used only for retrieval. We used conditional logistic regression to estimate diagnostic sensitivity and specificity.
RESULTS: The median BIMC of dementia cases was 10, indicating mild dementia. CCR had much higher sensitivity (93%) and specificity (99%) than ICR (53%, 94%), PA (68%, 91%), and LM (48%, 92%). CCR had the greatest advantage in the mildest cases.
CONCLUSIONS: CCR has substantially higher sensitivity and specificity for diagnosis of early dementia than memory tests that do not coordinate acquisition and retrieval. Superior discrimination by CCR is due to an encoding specificity deficit in dementia that increases the difference in recall by cases and controls. CCR is an efficient test with excellent discriminative validity that should facilitate diagnosis of early dementia.

Entities:  

Mesh:

Year:  1997        PMID: 9109889     DOI: 10.1212/wnl.48.4.989

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

Review 1.  Diagnosis and management of dementia in primary care at an early stage: the need for a new concept and an adapted procedure.

Authors:  J De Lepeleire; J Heyrman
Journal:  Theor Med Bioeth       Date:  1999-06

Review 2.  Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease.

Authors:  M Simard; R van Reekum
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

3.  Scenery Picture Memory Test: a new type of quick and effective screening test to detect early stage Alzheimer's disease patients.

Authors:  Hajime Takechi; Hiroko H Dodge
Journal:  Geriatr Gerontol Int       Date:  2010-04       Impact factor: 2.730

Review 4.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

5.  Mild Alzheimer's disease: a "position paper".

Authors:  J Delrieu; T Voisin; S Andrieu; S Belliard; J Belmin; F Blanchard; M Ceccaldi; J F Dartigues; B Defontaines; S Lehericy; C Mekies; O Moreaud; L Naccache; F Nourhashemi; P J Ousset; F Pasquier; P Payoux; F Puisieux; P Robert; J Touchon; B Vellas; B Dubois
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

6.  Age-related differences on event-related potentials and brain rhythm oscillations during working memory activation.

Authors:  Pascal Missonnier; François R Herrmann; Christelle Rodriguez; Marie-Pierre Deiber; Phiippe Millet; Lara Fazio-costa; Gabriel Gold; Panteleimon Giannakopoulos
Journal:  J Neural Transm (Vienna)       Date:  2011-02-18       Impact factor: 3.575

7.  The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's disease.

Authors:  Raquel Lemos; Diana Duro; Mário R Simões; Isabel Santana
Journal:  Arch Clin Neuropsychol       Date:  2014-07-25       Impact factor: 2.813

Review 8.  Early neuropsychological detection of Alzheimer's disease.

Authors:  C Bastin; E Salmon
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

Review 9.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

10.  Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression.

Authors:  Ulla Knorr; Maj Vinberg; Marianne Klose; Ulla Feldt-Rasmussen; Linda Hilsted; Anders Gade; Eva Haastrup; Olaf Paulson; Jørn Wetterslev; Christian Gluud; Ulrik Gether; Lars Kessing
Journal:  Trials       Date:  2009-08-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.